rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Arun Das

Chief Business Officer

Company insider

Files Form 4 as: Chief Business Officer, Cabaletta Bio.

In numbers

Trades disclosed
16
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
18 Jan 2022
Last trade
2 Mar 2026
Last filed
2 Mar 2026

Companies traded

Where they are an officer
CABA Cabaletta BioOfficer · Biotechnology · last 2 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Mar 2026filed 2 Mar 2026CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—175,000 at $0.00filing
2 Mar 2026filed 2 Mar 2026CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—175,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code D—18,416 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—18,416 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code D—35,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code D—100,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code D—150,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code D—100,000 at $0.00filing
19 May 2025filed 19 May 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
3 Mar 2025filed 4 Mar 2025CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—115,000 at $0.00filing
1 Mar 2024filed 4 Mar 2024CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
18 Jan 2023filed 27 Jan 2023CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
18 Jan 2022filed 19 Jan 2022CABA Cabaletta Biooption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Richard C. Henriques Jr.Director · Director at Cabaletta Bio, filing Form 4 there in the last year
Mark SimonDirector · Director at Cabaletta Bio, filing Form 4 there in the last year
Shawn TomaselloDirector · Director at Cabaletta Bio, filing Form 4 there in the last year
Catherine BollardDirector · Director at Cabaletta Bio, filing Form 4 there in the last year
Scott C. BrunDirector · Director at Cabaletta Bio, filing Form 4 there in the last year